{"DataElement":{"publicId":"10906709","version":"1","preferredName":"Laboratory Procedure Diphtheria Vaccine Antibody Performed Titer Outcome","preferredDefinition":"The outcome of the diphtheria vaccine antibody titer.","longName":"DIPTH_VCN_TTR_OTCM","context":"COG","contextVersion":"1","DataElementConcept":{"publicId":"8177597","version":"1","preferredName":"Laboratory Procedure Diphtheria Vaccine Antibody Performed","preferredDefinition":"Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting.:A Gram-positive bacterial infection caused by Corynebacterium diphtheriae. It usually involves the oral cavity, pharynx, and nasal cavity. Patients develop pseudomembranes in the affected areas and manifest signs and symptoms of an upper respiratory infection. The diphtheria toxin may cause myocarditis, polyneuritis, and other systemic effects._Preparations containing substances with antigenic properties administered to activate the immune system, thereby inducing an immune response._A type of protein made by B lymphocytes in response to a foreign substance (antigen). Each antibody only binds to a specific antigen, helping to destroy the antigen directly or by assisting white blood cells to destroy the antigen._Executed and carried through to completion.","longName":"8177594v1.0:8177595v1.0","context":"COG","contextVersion":"1","ObjectClass":{"publicId":"2543047","version":"1","preferredName":"Test","preferredDefinition":"A procedure for critical evaluation; a means of determining the presence, quality, or truth of something.","longName":"C25294","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Laboratory Procedure","conceptCode":"C25294","definition":"Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2262D258-9F2F-4D98-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-16","endDate":null,"createdBy":"IVERSONJ","dateCreated":"2006-11-16","modifiedBy":"ONEDATA","dateModified":"2006-11-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"11153412","version":"1","preferredName":"Diphtheria Vaccine Antibody Performed","preferredDefinition":"A Gram-positive bacterial infection caused by Corynebacterium diphtheriae. It usually involves the oral cavity, pharynx, and nasal cavity. Patients develop pseudomembranes in the affected areas and manifest signs and symptoms of an upper respiratory infection. The diphtheria toxin may cause myocarditis, polyneuritis, and other systemic effects._Preparations containing substances with antigenic properties administered to activate the immune system, thereby inducing an immune response._A type of protein made by B lymphocytes in response to a foreign substance (antigen). Each antibody only binds to a specific antigen, helping to destroy the antigen directly or by assisting white blood cells to destroy the antigen._Executed and carried through to completion.","longName":"C34541:C923:C16295:C38000","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Diphtheria","conceptCode":"C34541","definition":"A Gram-positive bacterial infection caused by Corynebacterium diphtheriae. It usually involves the oral cavity, pharynx, and nasal cavity. Patients develop pseudomembranes in the affected areas and manifest signs and symptoms of an upper respiratory infection. The diphtheria toxin may cause myocarditis, polyneuritis, and other systemic effects.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Vaccine","conceptCode":"C923","definition":"Preparations containing substances with antigenic properties administered to activate the immune system, thereby inducing an immune response.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Antibody","conceptCode":"C16295","definition":"A type of protein made by B lymphocytes in response to a foreign substance (antigen). Each antibody only binds to a specific antigen, helping to destroy the antigen directly or by assisting white blood cells to destroy the antigen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Performed","conceptCode":"C38000","definition":"Executed and carried through to completion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E7164E63-F9F9-2087-E053-731AD00ACD43","latestVersionIndicator":"Yes","beginDate":"2022-08-25","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-08-25","modifiedBy":"KUMMEROA","dateModified":"2022-08-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DDA77C94-F48C-307D-E053-4EBD850A0FBD","latestVersionIndicator":"Yes","beginDate":"2022-04-27","endDate":null,"createdBy":"LUY","dateCreated":"2022-04-27","modifiedBy":"KUMMEROA","dateModified":"2022-08-25","changeDescription":"Created for COG ASCT2031.  ylu, 04/27/2022","administrativeNotes":"2022.8.25 Released. ak","unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"10906707","version":"1","preferredName":"Vaccine Titer Outcome","preferredDefinition":"Preparations containing substances with antigenic properties administered to activate the immune system, thereby inducing an immune response._Concentration of a substance in a solution as determined by the quantitative reaction with added measured volume(s) of a solution of the precisely known concentration(s) of a standard reagent._The result of an action.","longName":"10906707v1.00","context":"COG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"15","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Immune","valueDescription":null,"ValueMeaning":{"publicId":"3192538","version":"1","preferredName":"Immune","longName":"3192538","preferredDefinition":"Protected against infectious disease by either specific or non-specific mechanisms. (On-line Medical Dictionary)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Immune","conceptCode":"C17997","definition":"Protected against infectious disease by either specific or non-specific mechanisms.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9C80BBD3-4C8F-2558-E040-BB89AD435ABF","latestVersionIndicator":"Yes","beginDate":"2011-02-17","endDate":null,"createdBy":"MAESKEB","dateCreated":"2011-02-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E543A5EF-9F7F-1586-E053-731AD00A75F4","beginDate":"2022-08-02","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-08-02","modifiedBy":"KUMMEROA","dateModified":"2022-08-02","deletedIndicator":"No"},{"value":"Non-Immune","valueDescription":null,"ValueMeaning":{"publicId":"10906708","version":"1","preferredName":"Negation Immune","longName":"10906708v1.00","preferredDefinition":"An operation in which a term denies or inverts the meaning of another term or construction._Protected against infectious disease by either specific or non-specific mechanisms.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Negation","conceptCode":"C25594","definition":"An operation in which a term denies or inverts the meaning of another term or construction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Immune","conceptCode":"C17997","definition":"Protected against infectious disease by either specific or non-specific mechanisms.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E543A5EF-9F7E-1586-E053-731AD00A75F4","latestVersionIndicator":"Yes","beginDate":"2022-08-02","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-08-02","modifiedBy":"KUMMEROA","dateModified":"2022-08-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E543A5EF-9F80-1586-E053-731AD00A75F4","beginDate":"2022-08-02","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-08-02","modifiedBy":"KUMMEROA","dateModified":"2022-08-02","deletedIndicator":"No"},{"value":"Inconclusive","valueDescription":null,"ValueMeaning":{"publicId":"5612326","version":"1","preferredName":"Indeterminate","longName":"5612326","preferredDefinition":"Cannot distinguish between two or more possible values in the current context.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Indeterminate","conceptCode":"C48658","definition":"Cannot distinguish between two or more possible values in the current context.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4533FADE-5652-7B40-E053-F662850A3056","latestVersionIndicator":"Yes","beginDate":"2017-01-03","endDate":null,"createdBy":"ALEYR","dateCreated":"2017-01-03","modifiedBy":"KUMMEROA","dateModified":"2022-08-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E543A5EF-9F81-1586-E053-731AD00A75F4","beginDate":"2022-08-02","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-08-02","modifiedBy":"KUMMEROA","dateModified":"2022-08-02","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"10906706","version":"1","preferredName":"Vaccine Titer Outcome","preferredDefinition":"Preparations containing substances with antigenic properties administered to activate the immune system, thereby inducing an immune response._Concentration of a substance in a solution as determined by the quantitative reaction with added measured volume(s) of a solution of the precisely known concentration(s) of a standard reagent._The result of an action.","longName":"10906706v1.00","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Vaccine","conceptCode":"C923","definition":"Preparations containing substances with antigenic properties administered to activate the immune system, thereby inducing an immune response.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Titer","conceptCode":"C67454","definition":"Concentration of a substance in a solution as determined by the quantitative reaction with added measured volume(s) of a solution of the precisely known concentration(s) of a standard reagent.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Outcome","conceptCode":"C20200","definition":"The result of an action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E5439DE5-F169-14A1-E053-731AD00A3584","latestVersionIndicator":"Yes","beginDate":"2022-08-02","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-08-02","modifiedBy":"KUMMEROA","dateModified":"2022-08-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E5439DE5-F16A-14A1-E053-731AD00A3584","latestVersionIndicator":"Yes","beginDate":"2022-08-02","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-08-02","modifiedBy":"CLOHNES","dateModified":"2022-09-07","changeDescription":null,"administrativeNotes":"9/7/22 Released VD per AK for COG cjl;","unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"PQT","type":"Preferred Question Text","description":"What was the outcome of the diphtheria vaccine antibody titer?","url":null,"context":"COG"},{"name":"COG CRF Text 1","type":"Alternate Question Text","description":"Diphtheria vaccine titer:","url":null,"context":"COG"}],"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E543CB30-E59C-19B6-E053-731AD00AF8EE","latestVersionIndicator":"Yes","beginDate":"2022-08-02","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-08-02","modifiedBy":"CLOHNES","dateModified":"2022-09-07","changeDescription":null,"administrativeNotes":"9/7/22 Released CDE per AK for COG cjl;","unresolvedIssues":null,"deletedIndicator":"No"}}